Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues

Journal of NeuroVirology

Volumn 6, Issue 2, 2000, Pages 145-155

  Hudson, Lance ^a   Liu, Jiankai ^b,c   Nath, Avindra ^b,d   Jones, Melina ^b   Raghavan, Ravi ^e   Narayan, Opendra ^f   Male, David ^a   Everall, Ian ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

^c JILIN UNIVERSITY   (China)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KANSAS   (United States)

Author keywords

AIDS; ELISA; HIV; RT PCR; Southern blot; Tat

Indexed keywords

TRANSACTIVATOR PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACACA; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SIMIAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034025075     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009013158     Document Type: Article

References (62)

1. Achim CL, Schrier RD, Wiley CA (1991). Immunopathogenesis of HIV encephalitis. Brain Pathol 3: 177-184.
2. Asare E, Dunn G, Glass J, McArthur J, Luthert P, Lantos P, Everall P (1996). Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. Am J Pathol 148: 31-38.
3. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996). Cellular reservoirs of HIV-1 in the central nervous systems of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10: 573-585.
4. Benjouad A, Mabrouk K, Moulard M, Gluckman JC, Rochart H, Van-Rietschoten J, Sabatier JM (1993). Cytotoxic effect on lymphocytes of Tat from human immunodiciency virus (HIV-1). FEBS Lett 319: 119-124.
5. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988). Neuronal cell killing by the envelope protein of HIV and its RC intestinal peptide. Nature 335: 639-6342.
6. Budka H, Wiley CA, Kleihues P, Artigas J, Ashbury AK, Cho ES, Cornblath DR et al (1991). HIV-associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1: 143-152.
7. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B (1997). HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 12: 1421-1431.
8. Cheng JA, Nath B, Knudsen S, Hochman JD, Geiger M, Ma DSK Magnuson (1998). Neuronal excitatory properties of human immunodeficiency virus type 1 tat protein. Neuroscience 82: 97-106.
9. Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces Tumor necrosis factor-α production: Implications for HIV-1 associated neurological diseases. J Biol Chem 272: 22385-22388.
10. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power RC, Gallo C, Major EO (1998). Induction of monocyte chemotactic protein-1 in HIV-1 Tat simulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci 95: 3117-3121.
11. Dawood MR, Allan R, Fowke KK, Embree J, Hammond GR (1992). Development of oligonucleotide primers and probes structural and regulatory genes of Human immunodeficiency virus type 1 (HIV-1) Provirus by using polymerase chain reaction. J Clin Microbiol 30: 2279-2283.
12. De la Monte SM, Gabuzda DH, Ho DD, Brown Jr RH, Hedley-Whyte ET, Schooley RT, Hirsch MS, Bhan AK (1988). Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 23: 485-492.
13. Desai K, Loewenstein PM, Green M (1991). Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter. Proc Natl Acad Sci USA 88: 8875-8879.
14. Dreyer EB, Kaiser PK, Offermannn JT, Lipton SA (1990). HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364-367.
15. Drysdale CM, Pavlakis GN (1991). Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency. J Virol 65: 3044-3051.
16. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 84-86.
17. Ensoli B, Buonaguro L, Barillari G, Fiorelli, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993). Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287.
18. Everall IP, Luthert PJ, Lantos PL (1991). Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119-1121.
19. Everall IP, Luthert PJ, Lantos PL (1993). Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 56: 481-486.
20. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J (1994). Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91: 664-668.
21. Foga IO, Nath A, Hasinoff B, Geiger JD. (1997). Antioxidants and dipyridamole inhibit human immunodeficiency virus type 1 (HIV-1) gp120 induced increases or reactive oxygen species in human monocytoid cells. J Acquir Immune Defic Syndr Hum Retroviral 16: 223-229.
22. Folks TM, Powell D, Lightfoote M, Koening S, Fanci AS, Benn S, Rabson A, Daugherty D, Gendelman HE, Hoggan MD, Venkateson S, Martin MA (1986). Biological and Biochemical characterization of a cloned Leu 3 cell surviving infection with the acquired immunodeficiency syndrome retrovirus. J Exp Med 164: 280-290.
23. Frankel AD, Pabo CO (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55: 1189-1193.
24. Gendelman HE, Persidsk Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997). The neuropathogenesis of the AIDS dementia complex. AIDS 11: S35-S45.
25. Jones M, Olafson K, del Bigio M, Peeling J, Nath A (1998). Intraventricular injection of human immunodeficiency virus type 1 Tat protein causes ventricular enlargement, inflammation, gliosis and apoptosis. J Neuropath Exp Neurol 57: 563-570.
26. Lei SZ, Zhang D, Abele AE, Lipton SA (1992). Blockade of NMDA receptor-mediated mobilization of intracellular Ca2+ prevents neurotoxicity. Brain Res 598: 196-202.
27. Lipton SA (1991). Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury. Ann Neural 30: 110-114.
28. Lipton SA (1992a). Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci 15: 75-79.
29. Lipton SA (1992b). Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 3: 913-915.
30. Ma M, Nath A (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495-2499.
31. Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995). Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neural 37: 373-380.
32. Mann DA, Frankel AD (1991). Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 10: 1733-1739.
33. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA (1992). Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 66: 285-291.
34. Masliah E, Ge N, Mucke L (1996). Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol 10: 57-67.
35. Mayne M, Bratanich A, Chen P, Pana F, Nath A, Power C (1998). HIV-1 Tat molecular diversity and induction of TNF-α: Implications for Tat-induced neurological disease. J Neuroimmunomodulat 5: 184-192.
36. Muller WE, Schroder HC, Ushijima H, Dapper J, Bormann J (1992). Gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 226: 209-214.
37. Munis JR, Kornbluth RS, Guatelli JC, Richman DD (1992). Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophage. J Gen Virol 73: 1899-1906.
38. Nath A, Geiger JD (1998). Neurobiological aspects of HIV infections: neurotoxic mechanisms. Prog Neurobiol 54: 19-33.
39. Nath A, Geiger JD, Mattson MP, Magnuson DSK, Jones M, Berger JR (1998). Role of viral proteins in neuropathogenesis of HIV infection with emphasis on Tat. NeuroAIDS 1: Oct.
40. Nath A, Conant K, Chen P, Scott C, Major EO (1999). Transient exposure to HIV-1 Tat protein results in an inflammatory response in brain and cytokine production in macrophages and astrocytes: A 'hit and run' phenomenon. J Biol Chem 274: 17098-17102.
41. Nath A, Padua RA, Geiger JD (1995). HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res 678: 200-206.
42. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DSK, Haughey N, Geiger J (1996). Identification of a HIV-1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70: 1475-1480.
43. New DR, Ma M, Epstein LG, Nath A, Gelbard HA (1997). Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary neuron cultures. J Neurovirol 3: 168-173.
44. Nuovo GJ, Gallery F, MacConnell P, Braun A (1994). In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol 144: 659-666.
45. Parmentier HK, van-Wichen DF, Meyling FH, Goudsmit J, Schuurman HJ (1992). Epitopes of human immunodeficiency virus regulatory proteins tat, nef and rev are expressed in normal human tissue. Am J Pathol 141: 1209-1216.
46. Pitlick FA, Nemerson Y (1976). Purification and characterization of tissue factor apoprotein. Methods Enzymol 45: 37-48.
47. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Clearly P (1988). The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586-592.
48. Purvis SF, Jacobberger JW, Sramkoski RM, Patki AH, Lederman MM (1995). HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS. Res Hum Retroviruses 11: 443-450.
49. Raghaven R, Stephens EB, Koag SV, Adany I, Pinson DM, Li Z, Jai F, Sahni M, Wang C, Leung K, Foresman L, Narayan O (1997). Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques. Brain Pathol 7: 851-861.
50. Ramazzotti E, Vignoli M, Re MC, Furlini G, La Placa M (1996). Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat transfected cells is associated with the presence of cell-surface bound Tat protein. AIDS 10: 455-461.
51. Sabatier JM, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, Bahraoui E (1991). Evidence for neurotoxic activity of Tat from human immunodeficiency virus type 1. J Virol 65: 961-967.
52. Strijbos PJ, Zamani MR, Rothwell NJ, Arbuthnott G, Harkiss G (1995). Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus. Neurosci Lett 197 215-218.
53. Sykova E (1997). The extracellular space in the CNS: Its regulation, volume and geometry in normal and pathological neuronal function. Neuroscientist 3: 28-41.
54. Tak-Man L, Fallert CJ, Piser TM, Thayer SA (1992). HIV envelope protein evokes intracellular calcium oscillations in rat hippocampal neurones. Brain Res 594: 189-196.
55. Tardieu M, Hery C, Peudenier S, Boespflug O, Montagnier L (1992). Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol 32: 11-17.
56. Toggas SM, Masliah E, Rockenstein EM, Mucke L (1994). Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193.
57. Tornatore C, Meyers, Atwood W, Conant K, Major E (1994). Temporal patterns of immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 68: 93-102.
58. Weeks BS, Lieberman DM, Johnson B, Roque E, Green M, Loewenstein P, Oldfield EH, Kleinman HK (1995). Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires, the Tat amino acid 49-58 basic domain. J Neurosci Res 42: 34-40.
59. Wesselingh SL, Takahashi K, Glass JD, McArthur JC, Griffin JW, Griffin DE (1997). Cellular localisation of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol 74: 1-8.
60. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500.
61. Wiley CA, Baldwin M, Achim CL (1996). Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843-847.
62. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafem M, Hansen L, Terry RD (1991). Neurocortical damage during HIV infection. Ann Neurol 29: 651-657.